The association between dyslipidaemia in the first trimester and adverse pregnancy outcomes in pregnant women with subclinical hypothyroidism: a cohort study.
Xueran WangEnjie ZhangZongyuan TianRong ZhaoKaikun HuangShen GaoShaofei SuShuanghua XieJianhui LiuYingyi LuanYue ZhangZheng ZhangYousheng YanWentao YueChenghong YinRuixia LiuPublished in: Lipids in health and disease (2024)
Among pregnant women with SCH, dyslipidaemia in early pregnancy was related to elevated risks of adverse pregnancy consequences. The combined consideration of age, pre-BMI, TSH, and lipid levels in the first trimester could be beneficial for monitoring patients and implementing interventions to reduce adverse pregnancy outcomes.
Keyphrases
- pregnancy outcomes
- pregnant women
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- body mass index
- prognostic factors
- peritoneal dialysis
- adverse drug
- quality improvement
- patient reported outcomes
- weight gain
- fatty acid
- risk assessment
- patient reported
- weight loss
- replacement therapy
- electronic health record